Live news related to VALERIO TX stock (FR0010095596): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on VALERIO TX mainly cover M&A activity, earnings publications et analyst notes. The stock trades at €0,46 on Euronext Paris, down 10,20% at the last update. This page lists the articles published on VALERIO TX stock to track the share price, company announcements and any item likely to influence market perception.
The settlement and delivery of shares issued in exchange for Etherna securities, which occurred on October 8, 2026, concluded a transaction based on a…
Valerio Therapeutics released its first-half accounts on October 7, 2026. Consolidated revenue reached €3,102 thousand, but net loss widened and cash …
The biotechnology company provided an update on its project to acquire the entire share capital of Etherna Immunotherapies.Authorization regarding for…
The laboratory listed on Euronext Growth Paris finances in cash and securities the acquisition of a Belgian company specializing in messenger RNA, whi…
Valerio Therapeutics has signed a binding offer to acquire 100% of Etherna Immunotherapies, a specialist in mRNA and lipid nanoparticle technologies. …
Valerio Therapeutics announced on Tuesday the appointment of Gilles Besin as CEO, effective from July 1, 2026. This transition marks a pivotal change …
